{"nct_id":"NCT05492578","title":"Long-Term Safety and Efficacy Evaluation of Amlitelimab in Participants of Previous Amlitelimab Moderate to Severe Atopic Dermatitis Clinical Trials","status":"RECRUITING","status_verified_date":"2025-08","start_date":"2022-08-22","start_date_type":"ACTUAL","primary_completion_date":"2028-12-13","primary_completion_date_type":"ESTIMATED","completion_date":"2028-12-13","completion_date_type":"ESTIMATED","phases":["PHASE2","PHASE3"],"tickers":["SNY"]}